SCHEMBL8796526

SCHEMBL8796526

COc1ccc2[nH]c(C)c(C(O)(C(=O)OC(C)(C)C)C(C)(C)C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C2 P52895 1/20 0.48
▸ HTR1D P28221 2/20 0.47
▸ HTR6 P50406 2/20 0.47
▸ MTNR1A P48039 3/20 0.46
▸ MTNR1B P49286 3/20 0.46
▸ ALDH1A1 P00352 9/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ KDM4E B2RXH2 5/20 0.43
▸ MAPT P10636 4/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HTR1E P28566 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8578417 0.78 AKR1C2 (0.55) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL5116957 0.77 AKR1C2 (0.58) AKR1C2HTR1DHTR6MTNR1AMTNR1B
Tert-Butanol SCHEMBL8796522 0.74 AKR1C2 (0.67) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL11488805 0.74 HTR6 (0.58) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL31676640 0.73 AKR1C2 (0.70) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL8578419 0.73 TRPV1 (0.51) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL8681641 0.73 AKR1C2 (0.70) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL4241544 0.71 MTNR1B (0.73) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL9267967 0.70 HTR1D (0.62) AKR1C2HTR1DHTR6MTNR1AMTNR1B
SCHEMBL5110673 0.69 ALDH1A1 (0.61) AKR1C2HTR1DHTR6MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0723442-A4 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS INC (US) 1997-06-11 — — EP disclosed
EP-0723442-A1 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS, INC. (US) 1996-07-31 — — EP disclosed
WO-1996003987-A1 LACTONE COMPOUNDS FOR TREATING PATIENTS WITH PRECANCEROUS LESIONS CELL PATHWAYS, INC. (US) 1996-02-15 — — WO disclosed
Send feedback